Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Inghirami

Showing results (1-10 of 99) with videos related to

Pageof 10
Sort By:
The American Journal of Dermatopathology|April 1, 1992
Large-cell acanthoma. A distinctive keratosisA D Rabinowitz, G Inghirami
Breast Cancer Research : BCR|March 16, 2001
The cyclin dependent kinase inhibitor p27 and its prognostic role in breast cancerR Chiarle, M Pagano, G Inghirami
Blood|March 1, 1994
Molecular genetic demonstration of the diverse evolution of Richter's syndrome (chronic lymphocytic leukemia and subsequent large cell lymphoma)A Matolcsy, G Inghirami, D M Knowles
Hematologic Pathology|January 1, 1992
The kinetics and temporal expression of T-cell activation-associated antigens CD15 (LeuM1), CD30 (Ki-1), EMA, and CD11c (LeuM5) by benign activated T cellsA Chadburn, G Inghirami, D M Knowles
The American Journal of Pathology|January 1, 1990
Hairy cell leukemia-associated antigen LeuM5 (CD11c) is preferentially expressed by benign activated and neoplastic CD8 T cellsA Chadburn, G Inghirami, D M Knowles
The American Journal of Pathology|June 1, 1990
Western thymomas lack Epstein-Barr virus by Southern blotting analysis and by polymerase chain reactionG Inghirami, M Chilosi, D M Knowles
Hematologic Pathology|January 1, 1992
T-cell activation-associated antigen expression by neoplastic T-cellsA Chadburn, G Inghirami, D M Knowles
Journal of Immunopharmacology|January 1, 1986
Complement receptors (CR) and cytotoxic responses: monoclonal antibodies directed against CR1 and CR3 inhibit the generation of human allospecific and virus specific cytotoxic cells in vitroG Inghirami, J D Lambris, G C Tsokos
Leukemia|July 9, 2016
Emerging therapies provide new opportunities to reshape the multifaceted interactions between the immune system and lymphoma cellsM Pizzi, M Boi, F Bertoni, et al.
Journal of Immunopharmacology|January 1, 1986
Regulation of human cytotoxic responses by complement: C3, C3b and C3d preparations enhance human allogeneic cytotoxic responsesG C Tsokos, G Inghirami, J D Lambris
Pageof 10

Showing results (1-10 of 99) with videos related to

Sort By:
Pageof 10
The American Journal of Dermatopathology|April 1, 1992
Large-cell acanthoma. A distinctive keratosisA D Rabinowitz, G Inghirami
Breast Cancer Research : BCR|March 16, 2001
The cyclin dependent kinase inhibitor p27 and its prognostic role in breast cancerR Chiarle, M Pagano, G Inghirami
Blood|March 1, 1994
Molecular genetic demonstration of the diverse evolution of Richter's syndrome (chronic lymphocytic leukemia and subsequent large cell lymphoma)A Matolcsy, G Inghirami, D M Knowles
Hematologic Pathology|January 1, 1992
The kinetics and temporal expression of T-cell activation-associated antigens CD15 (LeuM1), CD30 (Ki-1), EMA, and CD11c (LeuM5) by benign activated T cellsA Chadburn, G Inghirami, D M Knowles
The American Journal of Pathology|January 1, 1990
Hairy cell leukemia-associated antigen LeuM5 (CD11c) is preferentially expressed by benign activated and neoplastic CD8 T cellsA Chadburn, G Inghirami, D M Knowles
The American Journal of Pathology|June 1, 1990
Western thymomas lack Epstein-Barr virus by Southern blotting analysis and by polymerase chain reactionG Inghirami, M Chilosi, D M Knowles
Hematologic Pathology|January 1, 1992
T-cell activation-associated antigen expression by neoplastic T-cellsA Chadburn, G Inghirami, D M Knowles
Journal of Immunopharmacology|January 1, 1986
Complement receptors (CR) and cytotoxic responses: monoclonal antibodies directed against CR1 and CR3 inhibit the generation of human allospecific and virus specific cytotoxic cells in vitroG Inghirami, J D Lambris, G C Tsokos
Leukemia|July 9, 2016
Emerging therapies provide new opportunities to reshape the multifaceted interactions between the immune system and lymphoma cellsM Pizzi, M Boi, F Bertoni, et al.
Journal of Immunopharmacology|January 1, 1986
Regulation of human cytotoxic responses by complement: C3, C3b and C3d preparations enhance human allogeneic cytotoxic responsesG C Tsokos, G Inghirami, J D Lambris
Pageof 10